[

indian council of medical research

]
The Indian Council of Medical Research (ICMR) will start 4th national sero survey in June to assess Covid-19 spread.(AFP/ File photo)

Sero survey will help in building strategy on Covid vaccination: Experts

ANI | , New Delhi
UPDATED ON JUN 13, 2021 02:39 PM IST
  • The Centre recently announced that it would commence a nationwide sero surveillance project and has asked states to participate for fact-based monitoring of the situation.
ICMR had constituted a national task force headed by the director of All India Institute of Medical Science (AIIMS) Dr Randeep Guleria.(PTI photo)
ICMR had constituted a national task force headed by the director of All India Institute of Medical Science (AIIMS) Dr Randeep Guleria.(PTI photo)

ICMR Covid-19 task force to meet on Friday for review of plasma therapy

By hindustantimes.com | Edited by Ayshee Bhaduri, Hindustan Times, New Delhi
UPDATED ON MAY 13, 2021 02:51 PM IST
  • This meeting comes against the backdrop of clinicians and scientists in the country writing to the government's principal scientific advisor K Vijay Raghavan urging caution against the "irrational and non-scientific use" of convalescent plasma in treating Covid-19 patients in India.
The use of RT-PCR tests is recommended because RATs tend to have a high proportion of false negatives(AFP Photo)
The use of RT-PCR tests is recommended because RATs tend to have a high proportion of false negatives(AFP Photo)

ICMR’s guidelines push antigen tests amid surge

By Rhythma Kaul, New Delhi
UPDATED ON MAY 05, 2021 01:02 AM IST
So far, ICMR has approved 36 RAT kits. It has also advised setting up of dedicated 24x7 RAT booths at multiple locations in cities towns and villages.
Vials of Covaxin, a Covid-19 vaccine seen at Thane Civil hospital, in Thane, Mumbai. (Praful Gangurde / HT Photo)
Vials of Covaxin, a Covid-19 vaccine seen at Thane Civil hospital, in Thane, Mumbai. (Praful Gangurde / HT Photo)

ICMR says Covaxin effective in neutralising UK strain, double mutant variant

By hindustantimes.com | Written by Shankhyaneel Sarkar | Edited by Avik Roy, Hindustan Times, New Delhi
PUBLISHED ON APR 21, 2021 02:18 PM IST
In its study the ICMR also pointed out that the vaccine made by the Hyderabad-based pharmaceutical company is also effective against other variants like the Brazil variant as well the double mutant variant that has been detected in India.
A volunteer being vaccinated by a medic during the Bharat Biotech's 'Covaxin' human trial.(PTI File Photo)
A volunteer being vaccinated by a medic during the Bharat Biotech's 'Covaxin' human trial.(PTI File Photo)

Bharat Biotech recruits 23,000 volunteers for phase 3 clinical trial of Covaxin

Hindustan Times, New Delhi | By hindustantimes.com | Edited by Kanishka Sarkar
UPDATED ON JAN 02, 2021 10:28 PM IST
Covaxin, the indigenous Covid-19 vaccine, is being developed by Hyderabad-based Bharat Biotech in association with the Indian Council of Medical Research and National Institute of Virology.
Healthcare workers in PPE coveralls collect swab samples for Covid-19 test at Anand Vihar Bus Terminal in New Delhi, on Saturday.(Sanchit Khanna/HT Photo)
Healthcare workers in PPE coveralls collect swab samples for Covid-19 test at Anand Vihar Bus Terminal in New Delhi, on Saturday.(Sanchit Khanna/HT Photo)

‘Landmark peak, active Covid-19 cases lowest after 170 days’: Health ministry

Hindustan Times, New Delhi | By hindustantimes.com | Edited by: Amit Chaturvedi
UPDATED ON DEC 27, 2020 01:35 PM IST
The total number of active cases in the country stands at 2,78,690 while the total discharged cases are at 97,61,538 with 21,430 new discharges in the last 24 hours, according to health ministry tally.
Indian women take a selfie outside Sacred Hearth Cathedral which is closed to general public due to Covid-19 restrictions on the eve of Christmas in New Delhi, India.(AP)
Indian women take a selfie outside Sacred Hearth Cathedral which is closed to general public due to Covid-19 restrictions on the eve of Christmas in New Delhi, India.(AP)

61% of active Covid-19 cases in Delhi’s 5.5k hot spots: Delhi govt data

Hindustan Times, New Delhi | By Abhishek Dey, New Delhi
UPDATED ON DEC 26, 2020 05:18 AM IST
The government attributed the sharp increase in the share of active Covid-19 cases in red zones to its micro-containment policy, which was intensified in November.
A medic administers COVAXIN, an Indian government-backed experimental Covid-19 vaccine, to a health worker during its trials, at the Gujarat Medical Education & Research Society in Ahmedabad, India, November 26, 2020.(REUTERS)
A medic administers COVAXIN, an Indian government-backed experimental Covid-19 vaccine, to a health worker during its trials, at the Gujarat Medical Education & Research Society in Ahmedabad, India, November 26, 2020.(REUTERS)

Reading the clues from Covaxin early trial data

Hindustan Times, New Delhi | By Binayak Dasgupta
UPDATED ON DEC 25, 2020 04:59 AM IST
Bharat Biotech’s coronavirus vaccine candidate, jointly developed with the Indian Council of Medical Research (ICMR), passed the two crucial tests in clinical trials – showing it was safe and triggered an immune response – according to early stage analysis released on Wednesday.
Ambulance drivers lined up to drop recovered patients to their homes at Sardar Patel Covid Care Center in New Delhi, India.(Ajay Aggarwal /HT PHOTO)
Ambulance drivers lined up to drop recovered patients to their homes at Sardar Patel Covid Care Center in New Delhi, India.(Ajay Aggarwal /HT PHOTO)

Delhi govt trains 3,800 people for Phase 1 of Covid vaccination drive

Hindustan Times, New Delhi | By Anonna Dutt and Sweta Goswami
UPDATED ON DEC 25, 2020 02:23 AM IST
The vaccinators and the support staff will be taught about the different kinds of vaccines, how to administer them, how to ensure that the cold chain is maintained, what kind of adverse reactions might happen and what to do to combat these reactions, a senior official from the Delhi government said.
The South Korean company SD Biosensors is accused of not complying with the minimum requirement of sensitivity and specificity for the Covid tests. (Sakib Ali/HT Photo )
The South Korean company SD Biosensors is accused of not complying with the minimum requirement of sensitivity and specificity for the Covid tests. (Sakib Ali/HT Photo )

India bans Covid-19 rapid antigen test kits by Korean company for 7 days

Hindustan Times, New Delhi | By Anonna Dutt
UPDATED ON DEC 19, 2020 10:43 PM IST
This was the first rapid antigen kit to hit the market in mid-June, which debuted in Delhi when the government was looking to scale up testing fast amid a surge in the number of cases.
The National Expert Group on Vaccine Administration for Covid-19 (NEGVAC), headed by Dr Paul, has recommended that 10 million healthcare staff, 20 million frontline workers and 270 million people over the age of 50 or with co-morbidities be given the vaccines on priority once it becomes available.(AP)
The National Expert Group on Vaccine Administration for Covid-19 (NEGVAC), headed by Dr Paul, has recommended that 10 million healthcare staff, 20 million frontline workers and 270 million people over the age of 50 or with co-morbidities be given the vaccines on priority once it becomes available.(AP)

12 nations reached out to India for Covid vaccine: NITI Aayog’s VK Paul

Hindustan Times, New Delhi | By HT Correspondent
UPDATED ON DEC 19, 2020 07:37 PM IST
Dr Paul informed the GoM about the vaccine candidates in trial in India, the manufacturers, doses to become available and conditions for storage.
A health worker collects a swab sample to test for coronavirus infection, at UGC, ITO in New Delhi on Thursday.(Sanchit Khanna/HT Photo)
A health worker collects a swab sample to test for coronavirus infection, at UGC, ITO in New Delhi on Thursday.(Sanchit Khanna/HT Photo)

Record 90k tests, Covid-19 positivity rate below 2% for the third day in Delhi

Hindustan Times, New Delhi | By Anonna Dutt, New Delhi
UPDATED ON DEC 18, 2020 05:27 AM IST
The positivity rate has been below 5% for 15 days now, which experts believe is a sign of the spread of Covid-19 being in control.
People wait during the administration of Covaxin, a government-backed experimental Covid-19 vaccine, during its human trials, at the Gujarat Medical Education & Research Society in Ahmedabad, on Thursday.(PTI Photo)
People wait during the administration of Covaxin, a government-backed experimental Covid-19 vaccine, during its human trials, at the Gujarat Medical Education & Research Society in Ahmedabad, on Thursday.(PTI Photo)

No complaint from volunteers given Bharat Biotech’s Covaxin: Ahmedabad doctor

Hindustan Times, New Delhi | By hindustantimes.com | Edited by Meenakshi Ray
UPDATED ON NOV 27, 2020 05:41 PM IST
Dr Parul Bhatt, the medical superintendent of the Sola Civil Hospital in Gujarat’s Ahmedabad, said the second dose of Bharat Biotech International Limited’s Covid-19 vaccine will now be given after 28 days.
BMC health workers collect plasma samples from patients who recovered from Covid-19.(Vijayanand Gupta/HT Photo)
BMC health workers collect plasma samples from patients who recovered from Covid-19.(Vijayanand Gupta/HT Photo)

Indiscriminate use not advisable: ICMR’s advisory for plasma therapy for Covid-19 patients

Hindustan Times, New Delhi | By hindustantimes.com | Edited by Kanishka Sarkar
UPDATED ON NOV 18, 2020 12:14 PM IST
The study has concluded that the therapy “did not lead to a reduction in progression to severe Covid-19 or all-cause mortality in the group that received CPT as compared to the group that did not receive CPT”, ICMR said.
The Indian Council of Medical Research (ICMR) is also involved in the phase 3 testing of the two vaccine candidates.(AFP)
The Indian Council of Medical Research (ICMR) is also involved in the phase 3 testing of the two vaccine candidates.(AFP)

Two out of five Covid-19 vaccines in Phase 3 trial stage: Govt

Hindustan Times, New Delhi | By Rhythma Kaul
UPDATED ON NOV 18, 2020 06:32 AM IST
The two include the widely watched Oxford-AstraZeneca vaccine being tested by Serum Institute of India and the domestically developed candidate by Bharat Biotech.
A healthcare worker collects a swab sample from a man to test for coronavirus infection at a hospital in New Delhi on Sunday.(Biplov Bhuyan/HT Photo)
A healthcare worker collects a swab sample from a man to test for coronavirus infection at a hospital in New Delhi on Sunday.(Biplov Bhuyan/HT Photo)

Steep decline in daily Covid-19 numbers; recovery rate above 93%

Hindustan Times, New Delhi | By hindustantimes.com | Edited by: Amit Chaturvedi
UPDATED ON NOV 16, 2020 09:33 AM IST
New recoveries outnumbering fresh Covid-19 cases every 24-hour cycle has improved the recovery rate to 93.09 per cent, the Union health ministry said.
Covishield, a very First Covid 19 vaccine of Serum institute at Bharati hospital and research center in Pune.(Ravindra Joshi/HT File Photo)
Covishield, a very First Covid 19 vaccine of Serum institute at Bharati hospital and research center in Pune.(Ravindra Joshi/HT File Photo)

Covishield could be realistic solution to pandemic: SII on finishing phase 3 trial enrolment

Hindustan Times, New Delhi | By hindustantimes.com | Edited by Kanishka Sarkar
UPDATED ON NOV 12, 2020 10:54 AM IST
The SII said that the trials of the Oxford vaccine have shown promising results, which “so far give confidence that Covishield could be a realistic solution to the deadly pandemic”.
The rapid antigen test is also cheaper to perform as compared to the RT-PCR, which is a complicated test requiring a specialised laboratory.(Praful Gangurde/HT Photo)
The rapid antigen test is also cheaper to perform as compared to the RT-PCR, which is a complicated test requiring a specialised laboratory.(Praful Gangurde/HT Photo)

Rapid antigen tests account for close to 50% of Covid-19 tests in India: Govt data

Hindustan Times, New Delhi | By Rhythma Kaul
UPDATED ON NOV 11, 2020 06:49 PM IST
While RT-PCR is the gold standard for Covid-19 testing because of the high sensitivity of the test, RAT is preferred in areas where mass-scale testing needs to be deployed for it gives results in minutes and is cheaper
A vendor sells masks on a street in Chennai on June 15, 2020.(PTI)
A vendor sells masks on a street in Chennai on June 15, 2020.(PTI)

One-third of Chennai residents wear masks correctly: Survey

By Divya Chandrababu
PUBLISHED ON NOV 08, 2020 12:30 PM IST
The survey teams randomly selected 60 streets across all 15 zones in Chennai and “observed 30 individuals consecutively at each point twice a day in the morning (8-10 am) and evening (4-6 pm)”
A woman holds a small bottle labeled with a "Coronavirus Covid-19 Vaccine" sticker and a medical syringe in this illustration taken, October 30, 2020 (REUTERS/Dado Ruvic/File Photo)
A woman holds a small bottle labeled with a "Coronavirus Covid-19 Vaccine" sticker and a medical syringe in this illustration taken, October 30, 2020 (REUTERS/Dado Ruvic/File Photo)

Covid-19 vaccine update: Bharat Biotech candidate launch and AstraZeneca’s hopes

Hindustan Times, New Delhi | By hindustantimes.com | Edited by Karan Manral
UPDATED ON NOV 06, 2020 06:43 PM IST
Hungary has said it will import small doses of Russian-made Sputnik V for late stage trials, by December. Meanwhile, Australia has agreed to buy 50 million more doses of two more vaccine candidates.
Bharat Biotech’s Covaxin against coronavirus could be launched in February: Govt scientist
Bharat Biotech’s Covaxin against coronavirus could be launched in February: Govt scientist

Bharat Biotech’s Covaxin could be launched in Feb: Govt scientist

New Delhi | By Reuters
UPDATED ON NOV 05, 2020 04:23 PM IST
A launch in February would make COVAXIN the first India-made vaccine to be rolled out.
A health worker takes test tubes with plasma and blood samples after a separation process in a centrifuge during a coronavirus disease (COVID-19) vaccination study at the Research Centers of America.(REUTERS)
A health worker takes test tubes with plasma and blood samples after a separation process in a centrifuge during a coronavirus disease (COVID-19) vaccination study at the Research Centers of America.(REUTERS)

Pune hospitals find plasma therapy effective in moderate Covid-19 patients

Hindustan Times, Pune | By Steffy Thevar
UPDATED ON OCT 26, 2020 03:27 PM IST
ICMR study has found that this therapy is not as promising in bringing down the mortality rate
More research is likely needed to confirm that these are indeed a new major set of salivary glands, and if confirmed, it would be the first discovery of new salivary glands in about 300 years.(Netherlands Cancer Institute in Amsterdam)
More research is likely needed to confirm that these are indeed a new major set of salivary glands, and if confirmed, it would be the first discovery of new salivary glands in about 300 years.(Netherlands Cancer Institute in Amsterdam)

New glands found in the human body... in 2020!

Hindustan Times, New Delhi | By Rhythma Kaul, New Delhi
UPDATED ON OCT 22, 2020 08:10 AM IST
The new set of glands are about 1.5 inches on average and lie in the nasopharyngeal region, behind the nose and above the throat.
A health worker collects a swab sample from a man for coronavirus testing, at Pandit Deen Dayal Upadhyaya Marg, in New Delhi on Sunday, October 18, 2020.(Amal KS/HT PHOTO)
A health worker collects a swab sample from a man for coronavirus testing, at Pandit Deen Dayal Upadhyaya Marg, in New Delhi on Sunday, October 18, 2020.(Amal KS/HT PHOTO)

Delhi HC asks ICMR, CSIR to reply on pendency of approval to FELUDA test for Covid-19

New Delhi | By Asian News International | Posted by Kanishka Sarkar
PUBLISHED ON OCT 21, 2020 06:07 AM IST
The bench also noted that there have been repeated instances where the turnaround time for declaring the results has been crossing four days and said these things are unacceptable when a person tested is required to be isolated in that duration.
An auto rickshaw drives past a mural depicting frontline workers fighting against Covid-19 in New Delhi.(AP)
An auto rickshaw drives past a mural depicting frontline workers fighting against Covid-19 in New Delhi.(AP)

30 million frontline workers to get Covid-19 vaccine in phase 1

Hindustan Times, New Delhi | By Rhythma Kaul
UPDATED ON OCT 21, 2020 01:35 AM IST
The 30 million include 7 million doctors and paramedics, in addition to 20 million other frontline health workers, Union health secretary Rajesh Bhushan said on the sidelines of a Covid-19 media briefing on Tuesday.
A social worker puts a face mask on a boy in the wake of coronavirus pandemic during an awareness drive, in Bikaner.(PTI)
A social worker puts a face mask on a boy in the wake of coronavirus pandemic during an awareness drive, in Bikaner.(PTI)

No major mutation in Covid-19 virus in India, confirms PMO

Hindustan Times, New Delhi | By hindustantimes.com | Edited by Poulomi Ghosh
UPDATED ON OCT 17, 2020 05:52 PM IST
Indian Council of Medical Research has been conducting large-scale sequencing of nationally representative strains of SARS-CoV-2 virus collected for several months over different time periods.
PGIMER is expected to administer the vaccine to around 300 volunteers in phase 2 and 3 of the observer-blind, randomised, controlled study to determine the safety of Covishield (Covid-19 vaccine) and its immunogenicity (ability to provoke immune response) in healthy Indian adults.(REUTERS/For representation)
PGIMER is expected to administer the vaccine to around 300 volunteers in phase 2 and 3 of the observer-blind, randomised, controlled study to determine the safety of Covishield (Covid-19 vaccine) and its immunogenicity (ability to provoke immune response) in healthy Indian adults.(REUTERS/For representation)

No Oxford vaccine side effects in 53 volunteers at PGIMER

Hindustan Times, Chandigarh | By HT Correspondent, Chandigarh
UPDATED ON OCT 08, 2020 11:45 PM IST
PGIMER had screened 97 volunteers on Thursday, of whom 65 had already been vaccinated since September 25 when the institute started administering the first dose to volunteers
ICMR Director-General Balram Bhargava opined that Gandhi was aware and concerned about individual health(Virendra Singh Gosain/HT File Photo)
ICMR Director-General Balram Bhargava opined that Gandhi was aware and concerned about individual health(Virendra Singh Gosain/HT File Photo)

ICMR DG hails Gandhian perspective of healthy living in Covid-19 times

New Delhi | By Asian News International | Posted by Kanishka Sarkar
UPDATED ON OCT 03, 2020 10:13 AM IST
he ICMR Director-General opined that Gandhi was aware and concerned about individual health and poured his thoughts in the book “Key to Health”.
A healthcare worker wearing personal protective equipment (PPE) collects a swab sample from a woman, amid the spread of the coronavirus disease (COVID-19), in New Delhi.(REUTERS)
A healthcare worker wearing personal protective equipment (PPE) collects a swab sample from a woman, amid the spread of the coronavirus disease (COVID-19), in New Delhi.(REUTERS)

New devices developed for effective Covid-19 testing

Hindustan Times, New Delhi | By Anonna Dutt
UPDATED ON OCT 01, 2020 08:38 AM IST
The Centre for Augmenting War with Covid-19 Health Crisis (CAWACH) was created in April, with a corpus of Rs 56 crore, for scouting, evaluating, and supporting innovations that can help in the government’s fight against the pandemic.
A health worker collects a swab sample from a person to test for coronavirus infection at Bhagwati Vidya Mandir School in Madanpuri, Gurugram on Tuesday.(Parveen Kumar/HT Photo)
A health worker collects a swab sample from a person to test for coronavirus infection at Bhagwati Vidya Mandir School in Madanpuri, Gurugram on Tuesday.(Parveen Kumar/HT Photo)

88 million in India may have been exposed to Sars-Cov2: Sero survey

Hindustan Times, New Delhi | By Rhythma Kaul
UPDATED ON SEP 30, 2020 01:46 AM IST
Urban slum (15.6%) and non-slum (8.2%) areas had higher Sars-Cov2 infection prevalence than that of rural areas (4.4%), and prevalence in adults (above 18 years of age) was also higher at 7.1%, the findings show.
SHARE
  • 1
  • 2
  • 3
  • ...
Story Saved